STATE OF WISCONSIN INVESTMENT BOARD
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 854157
MADISON, WI
Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$552,220
+$15,280 QoQ
Shares Held
118,757
+19.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $511,704,326 across 163 Biotechnology names. AVIR ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,798 | $67,454,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,287 | $34,473,655 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
70,171 | $21,123,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
83,892 | $15,711,293 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
248,821 | $15,018,835 | |
| 6 | MRNA |
Moderna, Inc.
|
207,705 | $14,545,581 | |
| 7 | INSM |
INSMED Inc
|
118,057 | $12,587,237 | |
| 8 | RPRX |
Royalty Pharma plc
|
213,373 | $11,963,824 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $552,220 | 118,757 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $536,940 | 99,803 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $325,744 | 91,245 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $310,201 | 106,966 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $393,624 | 109,340 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $293,399 | 98,127 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $388,600 | 116,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $365,820 | 109,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $474,323 | 143,300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $520,756 | 128,900 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $396,195 | 129,900 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $369,600 | 123,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $591,294 | 158,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $639,766 | 190,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,035,362 | 215,252 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,030,271 | 181,067 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,246,348 | 175,542 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,182,636 | 163,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $747,384 | 83,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,931,016 | 83,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,795,728 | 83,600 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,241,175 | 20,100 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $839,778 | 20,100 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||